Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition

Overview of attention for article published in Human Molecular Genetics, October 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent: 3 patents

Readers on

mendeley: 141 Mendeley

So far, Altmetric has seen 3 patents that reference this research output.

PDE5 INHIBITOR FOR USE IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH…

Application EP-4154889-A1

European Patent Office

Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy

Grant US-11236336-B2

United States of America

Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy

Grant US-10626395-B2

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.